The clinical case of sildenafil administration in a very premature infant with pulmonary hypertension

We report the use of oral sildenafil in a 7-month-old preterm newborn with severe bronchopulmonary dysplasia and pulmonary arterial hypertension refractory to captopril and inhaled budesonide, and need of consistent oxygenation. Sildenafil was prepared as a powder for oral administration. Oral silde...

Full description

Saved in:
Bibliographic Details
Published in:Journal of pediatric and neonatal individualized medicine 2015-04, Vol.4 (1), p.e040108-e040108
Main Authors: Galina A. Alyamovskaya, Elena S. Keshishian, Elena G. Verchenko, Vera V. Bereznitskaya
Format: Article
Language:English
Subjects:
bronchopulmonary dysplasia
premature infants
pulmonary arterial hypertension
sildenafil
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:We report the use of oral sildenafil in a 7-month-old preterm newborn with severe bronchopulmonary dysplasia and pulmonary arterial hypertension refractory to captopril and inhaled budesonide, and need of consistent oxygenation. Sildenafil was prepared as a powder for oral administration. Oral sildenafil treatment was continued for 11 months. Oxygen supplement was suspended after 4 months and captopril administration was finished after 7 months of sildenafil treatment. There were no adverse effects during the treatment period. The respiratory failure decreased significantly and pulmonary arterial pressure became normal after 7 months of sildenafil treatment.
ISSN:2281-0692
DOI:10.7363/040108